To include your compound in the COVID-19 Resource Center, submit it here.

MDX-210 Bispecific antibody data

The Princeton, N.J., company reported data on patients who had failed multiple regimens

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE